The FOXO3a transcription factor is a target of cell survival and proliferative signaling by the NPM-ALK fusion kinase of anaplastic large cell lymphoma.

被引：0
|
作者：
Sternberg, DW
Gu, TL
Tothova, Z
Scheijen, B
Griffin, JD
Gilliland, DG
机构：
[1] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
78
引用
收藏
页码：25A / 25A
页数：1
相关论文
共 50 条
  • [21] ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors
    Lovisa, Federica
    Cozza, Giorgio
    Cristiani, Andrea
    Cuzzolin, Alberto
    Albiero, Alessandro
    Mussolin, Lara
    Pillon, Marta
    Moro, Stefano
    Basso, Giuseppe
    Rosolen, Angelo
    Bonvini, Paolo
    PLOS ONE, 2015, 10 (04):
  • [22] Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma
    W Piao
    D Chau
    L M Yue
    Y-L Kwong
    E Tse
    Leukemia, 2017, 31 : 522 - 526
  • [23] Arsenic trioxide degrades NPM-ALK fusion protein and inhibits growth of ALK-positive anaplastic large cell lymphoma
    Piao, W.
    Chau, D.
    Yue, L. M.
    Kwong, Y-L
    Tse, E.
    LEUKEMIA, 2017, 31 (02) : 522 - 526
  • [24] NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma
    Leventaki, Vasiliki
    Drakos, Elias
    Medeiros, L. Jeffrey
    Lim, Megan S.
    Elenitoba-Johnson, Kojo S.
    Claret, Francois X.
    Rassiclakis, George Z.
    BLOOD, 2007, 110 (05) : 1621 - 1630
  • [25] NPM-ALK regulated activation of the AP-1 transcription factor in anaplastic large cell lymphomas (ALCL)
    不详
    PATHOLOGY RESEARCH AND PRACTICE, 2005, 201 (03) : 223 - 224
  • [26] Identification of a novel crosstalk between casein kinase 2α and NPM-ALK in ALK-positive anaplastic large cell lymphoma
    Armanious, Hanan
    Gelebart, Pascal
    Anand, Mona
    Lai, Raymond
    CELLULAR SIGNALLING, 2013, 25 (02) : 381 - 388
  • [27] Trka, a Novel Binding Partner of NPM-ALK Oncogenic Tyrosine Kinase, Facilitates the Survival of T-Cell Anaplastic Large-Cell Lymphoma
    Shi, Wenyu
    George, Suraj Konnath
    Curry, Choladda V.
    Alkan, Serhan
    Amin, Hesham M.
    BLOOD, 2014, 124 (21)
  • [28] NPM-ALK regulated activation of the AP-1 transcription factor in anaplastic large cell lymphomas (ALCL)
    不详
    VIRCHOWS ARCHIV, 2005, 447 (02) : 150 - 151
  • [29] Gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma
    Lim, Megan
    Elenitoba-Johnson, Kojo
    MODERN PATHOLOGY, 2006, 19 : 116 - 117
  • [30] A NPM-ALK hybrid construct incorporating the Abl-kinase ATP-binding site as a paradigm for kinase inhibitor treatment of anaplastic large cell lymphoma.
    Miething, C
    Seipel, P
    Hoepfl, J
    Grundler, B
    Morris, S
    Peschel, C
    Duyster, J
    BLOOD, 2002, 100 (11) : 740A - 740A
12345